Open For Business Series – Interview Dr Mark Barrett, CEO
APC’s CEO Dr Mark Barrett, discusses Ireland’s involvement in the pharmaceutical industry and APC’s current plans on developing a COVID-19 vaccine in partnership with Vaxine Pty Ltd.
Cutting edge process development insights and news from APC.
APC’s CEO Dr Mark Barrett, discusses Ireland’s involvement in the pharmaceutical industry and APC’s current plans on developing a COVID-19 vaccine in partnership with Vaxine Pty Ltd.
Irish R&D firm APC partners with Australian biotech Vaxine to speed up COVID-19 vaccine candidate development, accelerating the time to patients.
APC has joined the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) as one of the 26 industrial partners.
A Message from the APC Team to Collaborators, "Now, more than ever, collaboration is vital."
Collaboration between Takeda and APC will design, optimize and deliver process improvements for Takeda’s portfolio of biologics-based medicines.
APC Hosted a Complimentary Workshop in Partnership With Nucleo Life Sciences on Technology Innovations in API and Drug Product Formulation Development.
APC and NIBRT join forces, expanding client access to biopharmaceutical services, enhancing process development and analytical capabilities.
APC Expanded its US Presence with New Offices in Cambridge, MA
APC wins the 2018 Biotech Company of the Year award.
Applied Process Company Ltd.completes a 10 million Euro expansion project.